SCHEMBL8633720

SCHEMBL8633720

NC(=O)c1cc([N+](=O)[O-])c(N(CCCl)CCCl)c([N+](=O)[O-])c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
GAA P10253 3/20 0.45
CYP3A4 P08684 2/20 0.45
ALDH1A1 P00352 2/20 0.45
PKM P14618 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TDP1 Q9NUW8 2/20 0.43
TSHR P16473 3/20 0.41
MAPK1 P28482 1/20 0.41
HCAR3 P49019 2/20 0.39
POLB P06746 2/20 0.39
CTPS1 P17812 1/20 0.39
MAPT P10636 4/20 0.38
LMNA P02545 4/20 0.38
HTT P42858 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
VCAM1 P19320 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637449 0.80 ALDH1A1 (0.55) SMN1; SMN2CYP3A4ALDH1A1TDP1MAPK1
Dimethylamine SCHEMBL8762028 0.78 CYP3A4 (0.42) SMN1; SMN2CYP3A4ALDH1A1L3MBTL1TDP1
SCHEMBL10344444 0.78 CYP3A4 (0.49) SMN1; SMN2GAACYP3A4ALDH1A1L3MBTL1
SCHEMBL8636087 0.76 MAPT (0.51) SMN1; SMN2GAAALDH1A1L3MBTL1MAPK1
SCHEMBL3421894 0.76 ALDH1A1 (0.50) SMN1; SMN2GAACYP3A4ALDH1A1TDP1
SCHEMBL8762462 0.75 ALDH1A1 (0.40) SMN1; SMN2GAACYP3A4ALDH1A1TDP1
SCHEMBL6570802 0.75 CYP3A4 (0.59) PARP1SMN1; SMN2GAACYP3A4ALDH1A1
SCHEMBL8760841 0.74 KMT2A (0.38) PARP1SMN1; SMN2GAACYP3A4ALDH1A1
SCHEMBL11762175 0.74 MAPK1 (0.73) SMN1; SMN2GAACYP3A4ALDH1A1L3MBTL1
SCHEMBL29411996 0.74 MAPT (0.47) PARP1SMN1; SMN2CYP3A4ALDH1A1HCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750782-A ANTICARCINOGENIC AGENTS, ANTIHYPOXIC AGENTS, PRODRUGS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1998-05-12 US disclosed
EP-0616609-B1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS CANCER RES CAMPAIGN TECH (GB) 1997-06-18 EP disclosed
US-5571845-A Nitroaniline derivatives and their use as anti-tumour agents CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-11-05 US disclosed
EP-0616609-A1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS. CANCER RES CAMPAIGN TECH (GB) 1994-09-28 EP disclosed
WO-1993011099-A1 NITROANILINE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1993-06-10 WO disclosed